Company: ECIA
Filing Date: 2025-08-15
Form Type: 10-Q
Source: 0001079973-25-001326
Chunk: 12

Company: ENCISION INC
Filing Date: 2025-08-15
Form: 10-Q
Item: Item 8
Chunk 12
---
 $150,298 of
total unrecognized compensation costs related to nonvested stock options is expected to be recognized over a period of five years.

    9 
    ENCISION INC. NOTES TO UNAUDITED CONDENSED INTERIM FINANCIAL STATEMENTS JUNE 30, 2025(Unaudited)

Note 6.	RELATED PARTY TRANSACTION

There were no related party transactions during the
three months ending June 30, 2025.

Note 7.	SUBSEQUENT EVENTS

We evaluated all of our activity as of the date the unaudited
condensed interim financial statements were issued and concluded that no subsequent events have occurred that would require recognition
in our financial statements or disclosed in the notes to our unaudited condensed interim financial statements.

10 

ITEM
2 - MANAGEMENT’S
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Certain statements contained in this section on Management’s
Discussion and Analysis are not historical facts, including statements about our strategies and expectations with respect to new and existing
products, market demand, acceptance of new and existing products, marketing efforts, technologies and opportunities, market and industry
segment growth, and return on investments in products and markets. These statements are forward-looking statements within the meaning
of the Private Securities Litigation Reform Act of 1995 and involve substantial risks and uncertainties that may cause actual results
to differ materially from those indicated by the forward-looking statements. All forward-looking statements in this section on Management’s
Discussion and Analysis are based on information available to us on the date of this document, and we assume no obligation to update such
forward-looking statements. Readers of this Form 10-Q are strongly encouraged to review the section entitled “Risk Factors”
in our Form 10-K for the fiscal year ended March 31, 2025.

General

Encision Inc., a medical device company based in Boulder,
Colorado, has developed and markets innovative technology that provides unprecedented outcomes and patient safety in minimally invasive
surgery. Approximately one in every three and three surgeons may have a patient injury each year from preventable stray energy burns.
We believe that our patented Active Electrode Monitoring (“AEM®”) AEM EndoShield™ Burn Protection System is changing
the marketplace for electrosurgical devices and laparoscopic instruments by providing a solution to a well-documented hazard unique to
laparoscopic surgery. The Center for Medicare and Medicaid Services has published its Hospital-Acquired Condition Reduction